The Materials That Should Exist

Biomaterials are shaped by interacting chemical, structural and biological factors that are difficult to optimise one at a time. We use experimental data and computational models to map these relationships, predict outcomes and identify candidate formulations for experimental testing.

Research approach

Designing biomaterials across interacting variables.

A biomaterial is not defined by composition alone. Its chemistry, structure and biological environment interact over time, and changes in one feature can affect several outcomes.

Our workflow treats these relationships as a connected design problem. Experimental material and biological data are used to identify influential variables, build predictive models and search for formulations that are more likely to meet predefined targets.

Each round of experiments provides new information about the design space and helps determine which measurements, formulations or conditions should be examined next.

Design workflow

A data-guided workflow for biomaterials design.

The workflow moves through four linked stages. MAP identifies influential variables in the design space. PREDICT uses measured data to estimate later or unmeasured outcomes. PRESCRIBE searches for formulations that match predefined targets, and VALIDATE compares those predictions with new experimental results.

MAP→ PREDICT→ PRESCRIBE→ VALIDATE↺
01 · MAP
Identify influential variables
Use structured experimental designs to determine which factors are most strongly associated with the outcome of interest.
MAP ▸
02 · PREDICT
Estimate later outcomes
Use early or partial measurements to estimate outcomes that would otherwise require longer or additional experiments.
PREDICT ▸
03 · PRESCRIBE
Search for target formulations
Search the modelled design space for candidate formulations predicted to match a defined property profile.
PRESCRIBE ▸
04 · VALIDATE
Test predictions experimentally
Compare predicted outcomes with material assays and cell models, then incorporate the resulting data into the next design cycle.
VALIDATE ▸
Map

Reducing the experimental search space.

Testing several formulation variables at multiple levels quickly generates a large number of possible combinations. Orthogonal arrays provide a structured way to sample that space and estimate selected effects with fewer runs than a full factorial design. In the example below, the objective is to examine how formulation variables influence setting time and compressive strength.

Study: formulation effects on setting time and compressive strength.
CHOOSE FACTORS · SET LEVELS

↳ POWERED BY THE HYPERFIELD ENGINE · DEVELOPING BIOMATERIALS FOR BETTER CARE
0 EXPERIMENTS
–

Material representation

Linking material features to experimental outcomes.

Composition, porosity, architecture and interfaces can be represented as measurable features and analysed alongside material properties and cell-response outcomes. This creates a common data structure in which relationships between material features and performance can be examined.

Illustration of a 3D-printed porous scaffold with connected struts and highlighted nodes.
SCAFFOLD ⇄ NETWORK

Models trained on these relationships can estimate outcomes for untested combinations and rank candidate formulations. These predictions should remain within the range supported by the available experimental data.

POROUS SCAFFOLD
Pore geometry and porosity.
FIBROUS NETWORK
MTA content, pore size, fibre diameter and number of layers.
LIVING INTERFACE
Cell response at the material surface.
Predictors

Selecting variables that improve prediction.

Adding more measurements does not necessarily improve a predictive model. For a given outcome, a subset of variables may contain most of the useful predictive information, while additional inputs contribute little. This module shows how predictive performance changes as variables are introduced one at a time.

HOW WELL CAN THE MODEL PREDICT?
TARGET
NO FACTORS SELECTED

Choose an application, then add factors to see how each one changes predictive performance.

ILLUSTRATIVE EXAMPLE · NOT STUDY DATA
↳ POWERED BY THE RESONANCE ENGINE · DEVELOPING BIOMATERIALS FOR BETTER CARE
Prediction

Predicting 28-day pH from early measurements.

As calcium-silicate cement hydrates, hydroxyl ion release raises the pH of the surrounding environment. Early pH measurements capture part of that developing alkalinity. Here, measurements at 3 h and 24 h, together with specimen surface area, are used to estimate the subsequent 28-day pH profile and compare it with experimental measurements.

ALKALINITY · pH OVER 28 DAYS FORECAST PLATEAU –
YOUR GOAL
Target 28-day pH10.5

The pH target at 28 days. The shaded band marks the target range.

EARLY READINGS · MODEL INPUTS
pH at 3 h8.0
pH at 24 h9.2
Specimen surface area169 mm²

ILLUSTRATIVE EXAMPLE · NOT STUDY DATA
↳ POWERED BY THE JANUS ENGINE · DEVELOPING BIOMATERIALS FOR BETTER CARE
Optimisation

Optimising formulations under competing property targets.

Material properties do not always improve in the same direction. Increasing radiopacifier content can improve radiopacity while reducing strength, while increasing water can improve flow but delay setting. The genetic algorithm therefore evaluates candidate formulations against several selected property targets at the same time.

Each candidate formulation is scored against the target profile. Better-matching candidates contribute to subsequent generations, shifting the population toward regions of the design space that better satisfy the selected constraints. The result is a search for the best overall compromise rather than a formulation that maximises every property independently.

GENERATION 0 GEN 0 / 16
Star-field illustration of a branching tree structure beside the profile of a bearded man.
SET THE TARGET

Set the property targets, then press PLAY to evolve the candidate formulations.

FITNESS · HOW WELL THE BEST FORMULATION MATCHES THE TARGET
HIGHLOW
↳ POWERED BY THE DARWINIAN ENGINE · DEVELOPING BIOMATERIALS FOR BETTER CARE
Workflow extension

Extending the design workflow toward translation.

MAP, PREDICT, PRESCRIBE and VALIDATE describe the current research workflow. New experimental results can be returned to the dataset to refine subsequent predictions and design decisions. TRANSLATE represents the longer-term extension of this process, in which validated materials and models are evaluated under increasingly clinically relevant conditions.

CURRENT LOOP
04 STAGES + TRANSLATE

Design space. The cube shows three factors at three levels; the nine amber points are the runs actually tested.

01MAP
Screen

Structured experimental designs identify variables associated with material performance.

Digital BioScore

Integrating multiple dimensions of cell response.

A material can perform differently across proliferation, migration and mineralisation assays, so no single endpoint provides a complete description of its in vitro biological response. The Digital BioScore combines these measurements into an integrated profile while preserving the contribution of each individual domain. The holographic representation is used to visualise how these domains vary together across materials.

DBS · HOLOGRAM
DBS · P
Proliferation
cells multiply
DBS · M
Migration
cells move
DBS · Mi
Mineralisation
mineral is deposited
DBS · ALL
Integrated
combined profile
↳ POWERED BY THE HOLOGRAM ENGINE · DEVELOPING BIOMATERIALS FOR BETTER CARE
Five-year horizon

Future directions: patient-specific prediction and automated discovery.

The next stage of the programme is to connect material design with patient-level information and increasingly automated experimentation. The longer-term objective is to move from formulations developed for average conditions toward candidates selected according to the biological and clinical constraints of individual cases.

CLINICAL PREDICTION

Models that combine material characteristics with patient-level data to estimate how candidate materials may perform under the conditions of a specific case.

AUTONOMOUS DISCOVERY

Experimental systems that can propose, test and refine candidate formulations iteratively, while scientists define the biological question, objectives and constraints.

Published evidence

Published evidence supporting the workflow.

The current workflow builds on three published studies that address different stages of biomaterials design. One used structured experimental design to tune material properties, another used early measurements to predict 28-day alkalinity, and a third used data-driven optimisation to identify formulations matching predefined property targets.

HOW THE STUDIES CONNECT Together, these studies establish components of a workflow in which experimental design narrows the space to be explored, predictive models estimate outcomes that have not yet been measured, and optimisation methods identify candidate formulations for targeted testing. Each stage remains anchored to experimental data and is evaluated against measured outcomes.
Research principle

The role of AI in the experimental workflow.

Across the programme, AI and statistical modelling are used to organise complex design spaces, identify informative variables, estimate outcomes and search for candidate formulations. The scientific questions, experimental constraints and interpretation remain defined by researchers, and computational predictions are evaluated against laboratory evidence.